HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Zacks Education
Visit Zacks'
Education section for investing guides and other free resources to make you a better investor.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive


ENZN: Enzon Pharmaceuticals Inc - Detailed Stock Quote Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Quote |  Detailed Quotes |  Real Time |  Options Chain |  Greeks Montage
ENZON PHARMACEUTICALS INC (NASD)
ENZN 10.37 -0.16 (-1.52%) Vol.  245,440 16:00 ET
Last 10.37 Bid / Size 10.05x0
Net  -0.16 Ask / Size 10.80x0
% Change  -1.52 52 Wk High 10.80
High 10.61 52 Wk Low 4.37
Low 10.32 Volume 245,440
 
Insider Ownership 10.75% S&P 500 Member NO
Institutional Ownership % Beta 1.25
P/E (TTM) PEG Ratio
PE (forward) Price / Sales 2.53
 
Dividend N/A
Dividend Yield 0
Last Dividend Date N/A
5 Year Avg. Yield 0
Dividend Payout Ratio
 
Shares Outstanding 45,456,000
Market Capitalization 471,378,720
Last Split Date N/A
Split Factor N/A
Short Interest Ratio 11.33
 
% Change
4 Weeks 15.97
12 Weeks 46.86
52 Weeks 129.41
 
% Change Relative to S&P 500
4 Weeks 11.91
12 Weeks 35.57
52 Weeks 76.74

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research